user

BioCartis Idylla Testing for EGFR Mutations in Lung Adenocarcinoma Reveals Low Clinical Sensitivity for Detecting Exon 20 Insertion Alterations

被引：0
|
作者：
Zhong, E. [1 ]
Velu, P. [2 ]
Cong, L. [2 ]
Serrano, L. [2 ]
Solomon, J. [2 ]
Rennert, H. [2 ]
机构：
[1] New York Presbyterian Weill Cornell Med, Little Neck, NY USA
[2] Weill Cornell New York Presbyterian, New York, NY USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2022年 / 24卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST019
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] EGFR exon 20 insertion mutations: Incidence and clinicopathologic characteristics in US patients with lung adenocarcinoma
    Arcila, Maria E.
    Nafa, Khedoudja
    Chaft, Jamie E.
    Rekhtman, Natasha
    Zakowski, Maureen Frances
    Kris, Mark G.
    Ladanyi, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Clinicopathologic and molecular characteristics of Chinese lung adenocarcinoma patients with EGFR exon 20 insertion mutations
    Wang, Lifeng
    Liu, Zichen
    Wan, Zhiyi
    Jiang, Dong
    Zhang, Min
    Liu, Shuku
    Che, Nanying
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (04)
  • [3] CLINICAL, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF EGFR EXON 20 INSERTION MUTATIONS IN LUNG CANCER
    Costa, Daniel B.
    Yasuda, Hiroyuki
    Park, Eunyoung
    Yun, Cai-Hong
    Huberman, Mark S.
    Oxnard, Geoffrey R.
    Sequist, Lecia V.
    Riely, Gregory
    Soo, Ross
    Eck, Michael J.
    Kobayashi, Susumu S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S355 - S355
  • [4] A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
    Yan Chen
    Bo Jiang
    Yuange He
    Chu Zhang
    Wenjie Zhou
    Cheng Fang
    Dejian Gu
    Minxia Zhang
    Mei Ji
    Juntao Shi
    Xin Yang
    BMC Medical Genomics, 15
  • [5] A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
    Chen, Yan
    Jiang, Bo
    He, Yuange
    Zhang, Chu
    Zhou, Wenjie
    Fang, Cheng
    Gu, Dejian
    Zhang, Minxia
    Ji, Mei
    Shi, Juntao
    Yang, Xin
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [6] OSIMERTINIB AS TREATMENT FOR EGFR EXON 20 INSERTION-POSITIVE LUNG ADENOCARCINOMA
    Murano, Chihiro
    Igarashi, Akira
    Yamauchi, Keiko
    Inoue, Sumito
    Watanabe, Masafumi
    EXCLI JOURNAL, 2019, 18 : 893 - 898
  • [7] Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma
    Piotrowska, Zofia
    Fintelmann, Florian J.
    Sequist, Lecia V.
    Jahagirdar, Balkrishna
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : E204 - E206
  • [8] Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation
    Urban, Laszlo
    Doczi, Robert
    Vodicska, Barbara
    Tihanyi, Dora
    Horvath, Magdolna
    Kormos, Dora
    Takacs, Istvan
    Papai-Szekely, Zsolt
    Poka-Farkas, Zsuzsanna
    Varkondi, Edit
    Schwab, Richard
    Hegedus, Csilla
    Valyi-Nagy, Istvan
    Petak, Istvan
    CLINICAL LUNG CANCER, 2021, 22 (01) : E112 - E115
  • [9] EGFR Exon 20 Insertion Mutations in a Brazilian Lung Cancer Cohort: Challenges for the Identification and Clinical Features
    Negreiros, Izabella
    Montella, Tatiane
    Silva, Lucas Silva
    Paes, Rafael Duarte
    Zali, Mariano
    Galindo, Layla
    Visani, Filipe
    Afonso, Nathalia Gimenes
    De Marchi, Pedro
    Ferreira, Carlos Gil
    Dienstmann, Rodrigo
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S8 - S8
  • [10] EGFR exon 20 insertion mutations in lung adenocarcinoma: Prevalence, molecular heterogeneity, and clinicopathologic characteristics in our lung cancer patients
    Choughule, A.
    Philip, D. S. J.
    Jambhekar, N.
    Patil, V.
    Joshi, A.
    Naronha, V.
    Prabhash, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S40 - S40
12345